What does this research mean for the field?

Catatonia can arise in patients with prominent psychosocial vulnerabilities, such as co-occurring somatic symptom disorder, functional neurological symptom disorder, and dissociative disorder, and its remission can be maintained with careful dose adjustment of lorazepam and quetiapine. Novelty: ClaimNovelty.INCREMENTAL. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

To describe the presentation, course, and pharmacological management of catatonia arising in the context of severe psychosocial stress, functional neurological symptom disorder, and dissociative disorder.

August 27, 2026Psychiatry and Clinical Neurosciences ReportsOpen Access

Catatonia with prominent psychosocial factors: A case report

View Full Paper

Ask AI

Bookmark

Authors

HNHiroto NoguchiAsahikawa Medical University YOYuki OmiyaAsahikawa Medical College Hospital MHMasahiro HishiyamaAsahikawa Medical College Hospital

Discussion

Member takes

Implication

Case report reveals successful pharmacotherapy for catatonia associated with functional disorders and severe psychosocial stress, highlighting the importance of careful medication tapering.

Key Points

To describe the presentation, course, and pharmacological management of catatonia arising in the context of severe psychosocial stress, functional neurological symptom disorder, and dissociative disorder.
Assessed a man in his 40s presenting with sudden-onset catatonic, functional, and dissociative symptoms following acute psychosocial stress (N=1).
Monitored disease severity using the Bush–Francis Catatonia Rating Scale (BFCRS) during treatment with lorazepam and quetiapine.
Initial combination therapy with lorazepam 3 mg/day and quetiapine 600 mg/day reduced the baseline BFCRS score from 22 to 3 by hospital Day 34.
Attempted dose reductions of either medication prompted dose-dependent symptom re-emergence, whereas re-escalation achieved complete remission (BFCRS = 0) by discharge on Day 98 with no recurrence at 10 months.

Cite This Study

Noguchi et al. (2026) studied this question.

synapsesocial.com/papers/6a8fe9da10c91c1e92621d36 https://doi.org/10.1002/pcn5.70401

View Full Paper

Ask AI

Bookmark

Implication

Case report reveals successful pharmacotherapy for catatonia associated with functional disorders and severe psychosocial stress, highlighting the importance of careful medication tapering.

Catatonia with prominent psychosocial factors: A case report

Discussion

Member takes

Implication

Key Points

Cite This Study

Catatonia with prominent psychosocial factors: A case report

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider